Hepatitis C treatment at a fraction of the cost to be available soon


PETALING JAYA: Affordable Hepatitis C treatment will soon be available for patients once trials on generic drugs are completed.

The non-profit Drugs for Neglected Diseases initiative (DNDi), of which the Malaysian Health Ministry is a founding member, and Egyptian drug manufacturer Pharco Pharmaceuticals on Wednesday signed agreements covering clinical testing and scale-up of a Hepatitis C treatment regimen at a price of just under US$300 (RM1,166) at the International Liver Congress 2016 in Barcelona, Spain.

Start your ads-free experience now!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

China ready to work with Malaysia to build China-Malaysia community, says Li Qiang
Three-tier MM2H to be a permanent feature, says Tiong
China's Premier Li Qiang arrives in Malaysia for three-day official visit
Court of Appeal verdict shows SLS isn't a ‘busybody’, says lawyer
Victim dies a week after fight, Sabah cops reclassify case to murder
Police searching for drug case suspect who fled Beluran roadblock
Sacrificial buffalo escapes, breaks woman's leg in Menggatal
Nine arrested after foreigner found dead with stab wounds, head injury in Ipoh
Babagon villagers to get RM16.8mil concrete bridge in two years
Four to be charged with burglary of influencer Kieda Crepe's house

Others Also Read